Podcasts about United Therapeutics

covid-19 donald trump soul joe biden detroit keanu reeves alex jones robocop matrix resurrections soylent green ftw martine rothblatt united therapeutics

Play Episode Listen Later Feb 7, 2022 20:11

Vor dem Wochenende trat der amerikanische Leitindex auf der Stelle. Der Dow Jones ging beinahe unverändert aus dem Handel. Der S&Phingegen legte um 0,5 Prozent zu.

Revivicor My Soul, AoT#341

Trans Resister Radio

Play Episode Listen Later Jan 17, 2022 58:46

Anyone who is sick of it all, come listen to this podcast and join Aaron in saying FTW. Topics include: appearances on other shows, Patreon, transhumanist agenda, nothing makes sense, average person's viewpoint, charade of politics, no winning Covid situation, Trump supporters will follow him to any end, insurrection, coup, January 6, constantly changing story, Biden a total lame duck, 2024 election, crime, Robocop, Detroit, Martine Rothblatt's Pig Heart Revival, genetic engineering, United Therapeutics, Revivicor, Soylent Green, Matrix Resurrections, Keanu Reeves, Alex Jones

Moderna, Delta Airlines, Carnival, Booking, Enphase, United Therapeutics, Shopify - Opening Bell

Play Episode Listen Later Jan 13, 2022 12:05

Die Anleger an der Wall Street präsentierten sich gestern weitestgehend zurückhaltend. Der Anstieg der Inflation auf sieben Prozent bremste die gute Laune. Der Dow Jones ging mit einem kleinen Plus von 0,1 Prozent aus dem Handel.

Moderna, Delta Airlines, Carnival, Booking, Enphase, United Therapeutics, Shopify - Opening Bell

Play Episode Listen Later Jan 13, 2022 12:05

WeWork, Snap, Facebook, Zoom Video, Nvidia, Alibaba, Intel, United Therapeutics - Opening Bell

social nfl advocates former nfl player childhood cancer cancer awareness devon still united therapeutics

Play Episode Listen Later Oct 22, 2021 19:44

Der S&Pstieg gestern auf ein neues Allzeithoch. Am Ende des Tages legte er 0,3 Prozent zu. Dem Dow Jones gelang es nicht auf ein Rekordhoch zu steigen.

174. Devon Still, Former NFL Player & Advocate for Childhood Cancer Awareness

Hurdle

Play Episode Listen Later Aug 30, 2021 30:06

Wow. I probably say that word at least 15 times in today's episode with Devon Still, former NFL player, author, speaker, and advocate for childhood cancer awareness. In 2014, Devon's world was turned upside down when his then 4-year-old daughter Leah was diagnosed with stage 4 neuroblastoma in 2014 and given a 50-50 chance to survive. In today's episode, he talks me through all of it — from feeling powerless at her bedside to how he learned to embrace vulnerability. A huge thank you to United Therapeutics for setting up this conversation, as Devon recently partnered with them on a new "Braving NeuroBLASToma" campaign. SOCIAL @stillinthegame @emilyabbate @hurdlepodcast CHECK OUT THE NEW HURDLE WEBSITE! JOIN: THE *Secret* FACEBOOK GROUP LEAVE ME A VOICE MESSAGE! Whether you just want to say hi or have a question you want to ask, I'd love to hear from you! Bonus: Your listener question could be answered in an upcoming episode of the show! P.S. No topics are off limits. --- Send in a voice message: https://anchor.fm/hurdle/message

FDA Accepts Priority Review Request for Tyvaso DPI

PF News & Perspectives

Play Episode Listen Later Jun 24, 2021 5:52

Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article summarizing the review request for Tyvaso DPI to be used in patients with pulmonary arterial hypertension (PH) and PH associated with interstitial lung diseases (ILDs), including those with IPF. Tyvaso is currently approved by the Food and Drug Administration in the US, however, the examination of how an inhaled form of Tyvaso (Tyvaso DPI) might better assist patients with PH and PH-ILDs is currently under way by United Therapeutics. If you have ILD-induced pulmonary hypertension, have you ever spoken to your doctor about Tyvaso? Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com

food priority drug administration accepts ipf ild pulmonary fibrosis united therapeutics

Buck Angel Bucks the Trend: An Old-School Transexual on the New Transgender Movement

The Unspeakable Podcast

Play Episode Listen Later May 30, 2021 80:34

Buck Angel is an entrepreneur and a speaker and educator about transgender issues, particularly issues related to trans healthcare. Now in his late 50s, he transitioned from female to male in his late 20s and has more recently became a controversial figure in certain corners of the trans community. He talked with Meghan about why he's so controversial, what it's been like to spend decades on masculinizing hormone therapy, and why he's worried about the number of clinicians now prescribing such therapies to young people after minimal psychological counseling. For the record: at one point in the interview Buck mistakenly referred to the biotech entrepreneur Martine Rothblatt as Martine Rathbaum. He also suggested that Rothblatt, who is the founder of the biotech company United Therapeutics, is among the billionaire class. As of March 2021, United Therapeutics was reportedly worth $7.1 billion. Rothblatt herself, according to Forbes, is worth $390 million. Guest Bio: Buck Angel is an entrepreneur and educator in the area of trans male healthcare and sexual wellness. He has also been a groundbreaking figure in the porn industry, which you can learn about on his website and also in a documentary about his life, Mr. Angel, which was released in 2013 and premiered at the South by Southwest Film Festival.

south forbes trend bucks buck old school transexual buck angel transgender movement southwest film festival martine rothblatt united therapeutics

Derek Morris of United Therapeutics — The Future of Transplants, Organs, and Art

Build The Future

Play Episode Listen Later May 18, 2021 39:42

In this episode of Build the Future, we talk with Derek Morris, a Director of Engineering at United Therapeutics. At United Therapeutics they’re on a mission to develop novel, life-extending technologies for patients battling with lung disease. In addition to developing medicine and transplant technology, they’re also leading cutting-edge research on organ manufacturing (3D printing of organs) which Derek leads.This episode should be reclassified as a schedule 1 stimulant — full of energy and optimism, we go off track on a wild tangent adventure covering art, media, inputs, the future, the World's Fair, and of course the incredible work being done at UT to print 3D organs.To listen to more episodes and to stay connected, follow along athttps://www.buildthefuturepodcast.com/https://twitter.com/camwieseDon’t forget to leave a review and subscribe.Have a great week and until next time, go build!

director world future 3d engineering ut transplants organs united therapeutics derek morris

Dr. Taofeek Owonikoko Previews a Dynamic #ASCO21 Education Program Focused on Equity

ASCO Daily News

Play Episode Listen Later May 6, 2021 12:11

In this episode, Dr. Taofeek Owonikoko, lung cancer specialist at the Winship Cancer Institute at Emory University and chair of the 2021 ASCO Annual Meeting Education Program, discusses the diverse ways that cancer care equity will be featured during #ASCO21. Transcript ASCO Daily News: Welcome to the ASCO Daily News podcast. I'm Geraldine Carroll, a reporter for the ASCO Daily News. My guest today is Dr. Taofeek Owonikoko, a lung cancer specialist at the Winship Cancer Institute at Emory University. Dr. Owonikoko serves as the chair of the education program of the 2021 ASCO Annual Meeting. And he's here to tell us about the diverse sessions that will be featured this year. Dr. Owonikoko reports no conflicts of interest relating to our discussion today. His full disclosures and those relating to old episodes of the podcast are available at asco.org/podcast. Dr. Owonikoko, it's great to have you on the podcast today. Dr. Taofeek Owonikoko: Thank you. Glad to be here. ASCO Daily News: Health equity is the major theme of this year's Annual Meeting. And as you know, ASCO's President, Dr. Lori Pierce, has been focusing on patient care equity during her term. Can you tell us about how the concept of cancer care equity has been incorporated into the education program this year? Dr. Taofeek Owonikoko: Thank you very much. I actually want to use this opportunity for us to thank all the ASCO volunteers, who spent countless hours putting together a very educational program for the Annual Meeting. It's very difficult for me to come out and say [that] this is the best session to go to. I think all of the sessions are very important and educational. The challenges that we've faced with COVID-19 that is making this a virtual meeting, actually, I think is an opportunity for people to be able to participate in all these sessions. Having said that, there are some sessions that we intentionally placed within the Education Program based on how important we felt these topics were to our patients, to their caregivers, family members, and also to ASCO members. We want sessions that focus on various aspects of health equity from individual patient interaction with their providers, to patient experience within the larger context of how health care systems are built, and how we deliver care. Some of the sessions that I really encourage members to listen to and participate in will be--there is a session that is going to bring diverse viewpoints from across the world, not just in the U.S. We want to see how oncologists practice in a limited resource setting, how they go about taking care of patients, and how they are able to use the challenges that they face as a stepping stone to bring the best care forward for that patient. So we have this session where we're going to have a speaker from Uganda in Africa. We have another speaker from Pakistan representing the Asian viewpoint. We are going to have a speaker who will speak to delivering care to the inner city population here in the U.S. And that session will also have a speaker that will discuss how we take care of our patients within the Native American community here in the U.S. So you're going to see these diverse viewpoints that we feel will shed light on the important point that Dr. Pierce has been trying to make with the presidential theme, that we need to focus on every patient, everywhere in terms of equitable care delivery. ASCO Daily News: Intersectionality in cancer care is a topic that has been getting more attention over the past year. How will this issue be addressed during the Education Program? Dr. Taofeek Owonikoko: We've talked about determinants of health outcomes for patients. How we look at all of these issues in isolation, whether it's gender, sexual orientation, race or ethnic background, rural versus urban, big city versus small towns, and different regions of the world. There's actually now this emerging consensus that a lot of these factors actually do not stand alone. There is an intersection of where someone lives and what type of access they have to health care--where someone lives and what type of care providers, someone's gender, and their socioeconomic status influencing the outcomes of care that they get. So this session on intersectionality, I think will really bring this to the forefront of our discussion about how to address health inequities--that we don't want to focus on one issue at a time. All these issues are important and they are interrelated. I think this type of session will help all of us to understand that there's a lot going on that determines the outcome for patients, especially for patients with cancer. One additional session I want to highlight, which is also very important to the presidential theme is the session on viruses and cancer. While there is this pandemic with the COVID-19 virus that we are very aware of, what we also did not want to lose sight of is the fact that viruses are etiology for cancer. This has been a topic that we've been struggling with for decades. And now that everyone is paying attention to the COVID-19 virus and development of a vaccine to prevent the infection or make the severity less for those who eventually get infected, I think we also need to bring that focus back to what viruses have done as etiology for different types of cancer--from either neck cancer to cervical cancer to liver cancer. And bringing this session together which speaks to how viral infection could be a key driver of the geographical differences in incidence of cancer around the world, I think will be very important for ASCO members and the general audience attending the meeting. ASCO Daily News: Absolutely, well you spoke about the pandemic and of course today health care inequality is more relevant than ever. As you say, the pandemic has disproportionately affected people of color, so clearly changes must occur if the oncology field if it is to make strides in improving outcomes for patients of color, increasing representation in clinical trials, for example, improving access to precision medicine and more. So what do you hope that people will take away from this meeting, that will stay with them in the months and years ahead? Dr. Taofeek Owonikoko: Yeah, I'm very hopeful that at the end of the Annual Meeting, with all the offerings we have in terms of educational sessions and topical issues that we want to address and some of them very provocative, we will learn that we have to be honest and open. Some of these issues are not easy to discuss, but we have to confront them if we are going to get past that, and not just brush them aside but actually have genuine discussion and be open about what the challenges are. I think that, when we look at the impact of cancer care delivery and the disparate outcomes that we see across different minority communities, including people of color, this doesn't just start from where you're delivering care, it also has to do with how we actually develop treatments that are given to patients. And nothing brings that to the surface [more] than what we've observed in terms of participation of people of color in cancer clinical trials. I know that this is a vaccine issue it's not something that I just started today, but we have to then become more systematic as to how we address it. If we are going to develop drugs that are going to be applicable to all populations, we have to be intentional in making sure that we have equitable and fair representation of all people, and that the treatment would be applicable too, so that we can start learning right from the beginning of the earliest stages of drug development. Whether there are unique differences in the way these drugs work, whether there are cultural influences that would determine whether or not the way we want to administer the drug is going to have any impact. And I want to use this to highlight one session that we have put together that's going to talk about minority patient enrollment in clinical trials. This session is not about the problem. We all recognize what the problem is. This is actually a session that is meant to show potential solutions, where we invited experienced investigators in this area to talk about gaps in how we conduct clinical trials, and what can be done to improve that process. They will talk about communications and blind-spots that we as oncologists and investigators may not even be aware of when we talk about clinical trials and we want someone to participate--what are the things that we can do to make sure that we convey the information about this study in a culturally appropriate manner, so that our own attitude of presenting the trial does not alienate and discourage participation from people of color and other minority groups? And then, there will be a talk about a real world experience of a large trial where key factors led to success in recruiting people of color on a large randomized phase III trial of prostate cancer that will be shown and shared with the audience. And people can take this back home to their individual practices and countries to see whether or not some of these strategies will also be applicable to them to help get around this problem of poor enrollment of minority patients in cancer clinical trials. ASCO Daily News: Thank you, Dr. Owonikoko, for highlighting some of these important issues on minority enrollment in cancer clinical trials, intersectionality, and cancer care, the management of DNA virus associated cancers, and the always popular ASCO voices session, which this year will use the power of the narrative to advocate for equity in cancer care. Dr. Owonikoko, thank you again for taking the time to speak with me today. Dr. Taofeek Owonikoko: Thank you. ASCO Daily News: And thank you to our listeners for joining us as well. If you're enjoying the content on the podcast, please take a moment to rate, and review us wherever you get your podcasts. Disclosures: Dr. Taofeek Owonikoko Stock and Other Ownership Interests: Cambium Oncology Consulting or Advisory Role: Novartis, Celgene, Abbvie, Eisai, G1 Therapeutics, Takeda, Bristol-Myers Squibb, MedImmune, BerGenBio, Lilly, Amgen, AstraZeneca, PharmaMar, Boehringer Ingelheim, EMD Serono, Xcovery, Bayer, Merck, Jazz Pharmaceuticals, Zentalis, Wells Fargo, Ipsen, Eisai, Roche/Genentech, Janssen Speakers' Bureau: Abbvie Research Funding (Institution): Novartis, Astellas Pharma, Bayer, Regeneron, AstraZeneca/MedImmune, Abbvie, G1 Therapeutics, Bristol-Myers Squibb, Corvus Pharmaceuticals, United Therapeutics, Amgen, Loxo/Lilly, Fujifilm, Pfizer, Aeglea Biotherapeutics, Incyte, Merck, Oncorus, Ipsen, GlaxoSmithKline, Calithera Biosciences, Eisai, WindMIL, Turning Point Therapeutics, Roche/Genentech, Mersana, Meryx, Boehringer Ingelheim Patents, Royalties, Other Intellectual Property (Institution): OVERCOMING ACQUIRED RESISTANCE TO CHEMOTHERAPY TREATMENTS THROUGH SUPPRESSION OF STAT3, SELECTIVE CHEMOTHERAPY TREATMENTS AND DIAGNOSTIC METHODS RELATED THERETO, DR4 Modulation and its Implications in EGFR-Target Cancer Therapy Ref:18089 PROV (CSP) United States Patent Application No. 62/670,210 June 26, 2018 (Co-Inventor), Soluble FAS ligand as a biomarker of recurrence in thyroid cancer; provisional patent 61/727,519 (Inventor) Other Relationship: Roche/Genentech, EMD Serono Uncompensated Relationships: Reflexion Medical Disclaimer: The purpose of this podcast, is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

covid-19 president africa dna cancer asian equity native americans focused pakistan implications uganda pfizer dynamic astrazeneca wells fargo emory university bayer oncology merck annual meetings royalties health disparities asco education programs amgen glaxosmithkline fujifilm abbvie bristol myers squibb takeda regeneron boehringer ingelheim ipsen eisai celgene asco annual meeting jazz pharmaceuticals co inventor emd serono winship cancer institute incyte united therapeutics medimmune pharmamar roche genentech disclosures dr g1 therapeutics owonikoko astrazeneca medimmune turning point therapeutics taofeek owonikoko

United Therapeutics UTHR Stock and A Mini CAR T Lesson

The Clinical Research Circle

Play Episode Listen Later Mar 5, 2021

Dan, Chris, Monica, and Dr Al discuss UTHR and CAR T Therapy

lesson stock united therapeutics

United Therapeutics - TYVASO® (treprostinil) INCREASE Study Data

Health Professional Radio - Podcast 454422

Play Episode Listen Later Feb 21, 2021 12:01

Dr. Leigh Peterson, Ph.D., Vice President of Product Development at United Therapeutics discusses data published in the "New England Journal of Medicine" (Jan 2021) on the INCREASE study evaluating Tyvaso in pulmonary hypertension associated with interstitial lung disease (PH-ILD). The INCREASE study is the first to demonstrate a clear benefit in patients with PH-ILD, a life-threatening disease with no currently FDA-approved treatments. She talks about what's next for Tyvaso as they look to achieve FDA approval. Leigh Peterson: In her role as Vice President, Product Development, Dr. Peterson is responsible for coordinating and managing all aspects of preclinical and clinical development of United Therapeutics’ products. Dr. Peterson joined United Therapeutics in 2008 as a Senior Clinical Research Scientist and was promoted to her current role as Vice President of Product Development in March 2017. Dr. Peterson received a BS in Biochemistry from the University of Wyoming, a PhD in Molecular Biology - Human Genetics from the University of Utah, and conducted postdoctoral research in Developmental Neurobiology at The Rockefeller University.

university phd data vice president medicine study utah bs fda wyoming peterson product development biochemistry new england journal rockefeller university united therapeutics developmental neurobiology

The Tony Robbins Podcast: The Wonder Woman who might save your life | Meet Martine Rothblatt, Sirius XM co-founder who now creates life-saving technologies

Hand Curated Episodes for learning by OwlTail

Play Episode Listen Later Dec 24, 2020

Published on 24 May 2019. After co-founding SiriusXM Radio, Martine Rothblatt took a leap of faith when her youngest daughter developed a fatal lung illness with no available treatment. Determined to help her daughter, and with no formal background in science or biology, she created United Therapeutics, which developed a lifesaving molecule that not only saved her daughter, but tens of thousands of others in the process – proving that when your WHY is strong enough, you’ll find the HOW. In this exclusive interview with Tony Robbins at one of his business seminars, Martine shares how she has built her entire career on achieving the seemingly impossible, and also reveals her own process for turning visionary ideas into technology that changes lives.

technology co founders wonder woman creates tony robbins published determined sirius xm martine lifesaving save your life sirius xm radio martine rothblatt united therapeutics tony robbins podcast

#487: Dr. Martine Rothblatt — A Masterclass on Asking Better Questions and Peering Into the Future

Philosophica

Play Episode Listen Later Dec 20, 2020 118:42

Podcast: The Tim Ferriss Show (LS 81 · TOP 0.01% what is this?)Episode: #487: Dr. Martine Rothblatt — A Masterclass on Asking Better Questions and Peering Into the FuturePub date: 2020-12-16Dr. Martine Rothblatt — A Masterclass on Asking Better Questions and Peering Into the Future | Brought to you by FreshBooks cloud-based small business accounting software, Headspace easy-to-use app with guided meditations, and Athletic Greens all-in-one nutritional supplement Dr. Martine Rothblatt (@skybiome) is Chairman and CEO of United Therapeutics, a biotechnology company she started to save the life of one of her daughters. The company offers FDA-approved medicines for pulmonary hypertension and neuroblastoma and is working on manufacturing an unlimited supply of transplantable organs.Dr. Rothblatt previously created and led Sirius XM as its Chairman and CEO and launched other satellite systems for navigation and international television broadcasting. In the field of aviation, her Sirius XM satellite system enhances safety with real-time digital weather information to pilots in flight nationwide. She also designed the world's first electric helicopter and piloted it to a Guinness world record for speed, altitude, and flight duration.In the legal arena, Dr. Rothblatt led efforts of the transgender community to establish their own health law standards and of the International Bar Association to protect autonomy rights in genetic information via an international treaty. She also published dozens of scholarly articles and papers on the law of outer space, resulting in her election to the International Institute of Space Law, and represented the radio astronomy community's scientific research interests before the Federal Communications Commission.She has bachelor's (communications studies, summa cum laude), JD (Order of the Coif) and MBA degrees from UCLA, which in 2018 awarded her its highest recognition, the UCLA Medal, and she holds a PhD in medical ethics from the Royal London School of Medicine and Dentistry. Her patented inventions cover aspects of satellite communication, medicinal biochemistry, and cognitive software.Dr. Rothblatt's recent books are on xenotransplantation (Your Life or Mine), gender identity (Transgender to Transhuman), and cyberethics (Virtually Human). She occasionally posts on Instagram at @transbinary and Twitter at @skybiome.Please enjoy!*This episode is brought to you by FreshBooks. I've been talking about FreshBooks—an all-in-one invoicing + payments + accounting solution—for years now. Many entrepreneurs, as well as the contractors and freelancers that I work with, use it all the time.FreshBooks makes it super easy to track things like expenses, project time, and client info, and then merge it all into great-looking invoices. FreshBooks can save users up to 200 hours a year on accounting and bookkeeping tasks. Right now FreshBooks is offering my listeners a free 30-day trial, and no credit card is required. Go to FreshBooks.com/Tim and enter “Tim Ferriss” in the “How did you hear about us?” section!*This episode is also brought to you by Headspace! Headspace is your daily dose of mindfulness in the form of guided meditations in an easy-to-use app. Whatever the situation, Headspace can help you feel better. Overwhelmed? Headspace has a 3-minute S.O.S. meditation for you. Need some help falling asleep? Headspace has wind-down sessions their members swear by. And for parents, Headspace even has morning meditations you can do with your kids. Headspace's approach to mindfulness can reduce stress, improve sleep, boost focus, and increase your overall sense of well-being.Go to Headspace.com/Tim for a FREE one-month trial with access to Headspace's full library of meditations for every situation.*This episode is also brought to you by Athletic Greens. I get asked all the time, “If you could only use one supplement, what would it be?” My answer is usually Athletic Greens, my all-in-one nutritional insurance. I recommended it in The 4-Hour Body in 2010 and did not get paid to do so. I do my best with nutrient-dense meals, of course, but AG further covers my bases with vitamins, minerals, and whole-food-sourced micronutrients that support gut health and the immune system. Right now, Athletic Greens is offering you their Vitamin D Liquid Formula free with your first subscription purchase—a vital nutrient for a strong immune system and strong bones. Visit AthleticGreens.com/Tim to claim this special offer today and receive the free Vitamin D Liquid Formula (and five free travel packs) with your first subscription purchase! That's up to a one-year supply of Vitamin D as added value when you try their delicious and comprehensive all-in-one daily greens product.*If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts/iTunes? It takes less than 60 seconds, and it really makes a difference in helping to convince hard-to-get guests. I also love reading the reviews!For show notes and past guests, please visit tim.blog/podcast.Sign up for Tim's email newsletter (“5-Bullet Friday”) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissFacebook: facebook.com/timferriss YouTube: youtube.com/timferrissThe podcast and artwork embedded on this page are from Tim Ferriss: Bestselling Author, Human Guinea Pig, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

#487: Dr. Martine Rothblatt — A Masterclass on Asking Better Questions and Peering Into the Future

Podcast Notes Playlist: Latest Episodes

Play Episode Listen Later Dec 20, 2020 118:42

Tim Ferriss Show Podcast Notes Key Takeaways To find your purpose is the best feeling ever, Martine describes it as “a lightning bolt to your soul”Science is about critical thinking and asking ‘Why’To cultivate more science in society, we have to relate it to people’s everyday livesPharmaceutical companies should get consent before mining genome data from remote isolated communities for the purpose of medicine development“I would say that one of the greatest unmet medical needs today is an adequate supply of transplantable organs”“I am absolutely convinced that in this decade, the 2020s, we will be delivering manufactured organs by electric helicopter” – Martine RothblattIn the future, people will be able to wear headsets that stimulate the vagus nerve to target particular ailments, with no pills or medical expenses“I believe this kind of bridging of electronics and the mind is really right around the corner” – Martine RothblattThe ability to create a technology doesn’t necessarily grant the right to make it, that right is coupled with the obligation to have the consent of whoever may be adversely affected by itIn a future full of innovation, techno-ethics is a field with rich possibilitiesHumans spewing greenhouse gases into an undeniably thin atmosphere, yet fearing nuclear energy, will seem barbaric to future generations“Identify the corridors of indifference and run like hell down them” – Martine RothblattRead the full notes @ podcastnotes.orgDr. Martine Rothblatt — A Masterclass on Asking Better Questions and Peering Into the Future | Brought to you by FreshBooks cloud-based small business accounting software, Headspace easy-to-use app with guided meditations, and Athletic Greens all-in-one nutritional supplement Dr. Martine Rothblatt (@skybiome) is Chairman and CEO of United Therapeutics, a biotechnology company she started to save the life of one of her daughters. The company offers FDA-approved medicines for pulmonary hypertension and neuroblastoma and is working on manufacturing an unlimited supply of transplantable organs.Dr. Rothblatt previously created and led Sirius XM as its Chairman and CEO and launched other satellite systems for navigation and international television broadcasting. In the field of aviation, her Sirius XM satellite system enhances safety with real-time digital weather information to pilots in flight nationwide. She also designed the world’s first electric helicopter and piloted it to a Guinness world record for speed, altitude, and flight duration.In the legal arena, Dr. Rothblatt led efforts of the transgender community to establish their own health law standards and of the International Bar Association to protect autonomy rights in genetic information via an international treaty. She also published dozens of scholarly articles and papers on the law of outer space, resulting in her election to the International Institute of Space Law, and represented the radio astronomy community’s scientific research interests before the Federal Communications Commission.She has bachelor’s (communications studies, summa cum laude), JD (Order of the Coif) and MBA degrees from UCLA, which in 2018 awarded her its highest recognition, the UCLA Medal, and she holds a PhD in medical ethics from the Royal London School of Medicine and Dentistry. Her patented inventions cover aspects of satellite communication, medicinal biochemistry, and cognitive software.Dr. Rothblatt’s recent books are on xenotransplantation (Your Life or Mine), gender identity (Transgender to Transhuman), and cyberethics (Virtually Human). She occasionally posts on Instagram at @transbinary and Twitter at @skybiome.Please enjoy!*This episode is brought to you by FreshBooks. I’ve been talking about FreshBooks—an all-in-one invoicing + payments + accounting solution—for years now. Many entrepreneurs, as well as the contractors and freelancers that I work with, use it all the time.FreshBooks makes it super easy to track things like expenses, project time, and client info, and then merge it all into great-looking invoices. FreshBooks can save users up to 200 hours a year on accounting and bookkeeping tasks. Right now FreshBooks is offering my listeners a free 30-day trial, and no credit card is required. Go to FreshBooks.com/Tim and enter “Tim Ferriss” in the “How did you hear about us?” section!*This episode is also brought to you by Headspace! Headspace is your daily dose of mindfulness in the form of guided meditations in an easy-to-use app. Whatever the situation, Headspace can help you feel better. Overwhelmed? Headspace has a 3-minute S.O.S. meditation for you. Need some help falling asleep? Headspace has wind-down sessions their members swear by. And for parents, Headspace even has morning meditations you can do with your kids. Headspace’s approach to mindfulness can reduce stress, improve sleep, boost focus, and increase your overall sense of well-being.Go to Headspace.com/Tim for a FREE one-month trial with access to Headspace’s full library of meditations for every situation.*This episode is also brought to you by Athletic Greens. I get asked all the time, “If you could only use one supplement, what would it be?” My answer is usually Athletic Greens, my all-in-one nutritional insurance. I recommended it in The 4-Hour Body in 2010 and did not get paid to do so. I do my best with nutrient-dense meals, of course, but AG further covers my bases with vitamins, minerals, and whole-food-sourced micronutrients that support gut health and the immune system. Right now, Athletic Greens is offering you their Vitamin D Liquid Formula free with your first subscription purchase—a vital nutrient for a strong immune system and strong bones. Visit AthleticGreens.com/Tim to claim this special offer today and receive the free Vitamin D Liquid Formula (and five free travel packs) with your first subscription purchase! That’s up to a one-year supply of Vitamin D as added value when you try their delicious and comprehensive all-in-one daily greens product.*If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts/iTunes? It takes less than 60 seconds, and it really makes a difference in helping to convince hard-to-get guests. I also love reading the reviews!For show notes and past guests, please visit tim.blog/podcast.Sign up for Tim’s email newsletter (“5-Bullet Friday”) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim’s books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissFacebook: facebook.com/timferriss YouTube: youtube.com/timferriss

#487: Dr. Martine Rothblatt — The Incredible Polymath of Polymaths

The Tim Ferriss Show

Play Episode Listen Later Dec 16, 2020 118:42

Dr. Martine Rothblatt — The Incredible Polymath of Polymaths | Brought to you by FreshBooks cloud-based small business accounting software, Headspace easy-to-use app with guided meditations, and Athletic Greens all-in-one nutritional supplement Dr. Martine Rothblatt (@skybiome) is Chairman and CEO of United Therapeutics, a biotechnology company she started to save the life of one of her daughters. The company offers FDA-approved medicines for pulmonary hypertension and neuroblastoma and is working on manufacturing an unlimited supply of transplantable organs.Dr. Rothblatt previously created and led Sirius XM as its Chairman and CEO and launched other satellite systems for navigation and international television broadcasting. In the field of aviation, her Sirius XM satellite system enhances safety with real-time digital weather information to pilots in flight nationwide. She also designed the world’s first electric helicopter and piloted it to a Guinness world record for speed, altitude, and flight duration.In the legal arena, Dr. Rothblatt led efforts of the transgender community to establish their own health law standards and of the International Bar Association to protect autonomy rights in genetic information via an international treaty. She also published dozens of scholarly articles and papers on the law of outer space, resulting in her election to the International Institute of Space Law, and represented the radio astronomy community’s scientific research interests before the Federal Communications Commission.She has bachelor’s (communications studies, summa cum laude), JD (Order of the Coif) and MBA degrees from UCLA, which in 2018 awarded her its highest recognition, the UCLA Medal, and she holds a PhD in medical ethics from the Royal London School of Medicine and Dentistry. Her patented inventions cover aspects of satellite communication, medicinal biochemistry, and cognitive software.Dr. Rothblatt’s recent books are on xenotransplantation (Your Life or Mine), gender identity (Transgender to Transhuman), and cyberethics (Virtually Human). She occasionally posts on Instagram at @transbinary and Twitter at @skybiome.Please enjoy!*This episode is brought to you by FreshBooks. I’ve been talking about FreshBooks—an all-in-one invoicing + payments + accounting solution—for years now. Many entrepreneurs, as well as the contractors and freelancers that I work with, use it all the time.FreshBooks makes it super easy to track things like expenses, project time, and client info, and then merge it all into great-looking invoices. FreshBooks can save users up to 200 hours a year on accounting and bookkeeping tasks. Right now FreshBooks is offering my listeners a free 30-day trial, and no credit card is required. Go to FreshBooks.com/Tim and enter “Tim Ferriss” in the “How did you hear about us?” section!*This episode is also brought to you by Headspace! Headspace is your daily dose of mindfulness in the form of guided meditations in an easy-to-use app. Whatever the situation, Headspace can help you feel better. Overwhelmed? Headspace has a 3-minute S.O.S. meditation for you. Need some help falling asleep? Headspace has wind-down sessions their members swear by. And for parents, Headspace even has morning meditations you can do with your kids. Headspace’s approach to mindfulness can reduce stress, improve sleep, boost focus, and increase your overall sense of well-being.Go to Headspace.com/Tim for a FREE one-month trial with access to Headspace’s full library of meditations for every situation.*This episode is also brought to you by Athletic Greens. I get asked all the time, “If you could only use one supplement, what would it be?” My answer is usually Athletic Greens, my all-in-one nutritional insurance. I recommended it in The 4-Hour Body in 2010 and did not get paid to do so. I do my best with nutrient-dense meals, of course, but AG further covers my bases with vitamins, minerals, and whole-food-sourced micronutrients that support gut health and the immune system. Right now, Athletic Greens is offering you their Vitamin D Liquid Formula free with your first subscription purchase—a vital nutrient for a strong immune system and strong bones. Visit AthleticGreens.com/Tim to claim this special offer today and receive the free Vitamin D Liquid Formula (and five free travel packs) with your first subscription purchase! That’s up to a one-year supply of Vitamin D as added value when you try their delicious and comprehensive all-in-one daily greens product.*If you enjoy the podcast, would you please consider leaving a short review on Apple Podcasts/iTunes? It takes less than 60 seconds, and it really makes a difference in helping to convince hard-to-get guests. I also love reading the reviews!For show notes and past guests, please visit tim.blog/podcast.Sign up for Tim’s email newsletter (“5-Bullet Friday”) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim’s books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissFacebook: facebook.com/timferriss YouTube: youtube.com/timferriss

Episode 357: PAH Today - Moving Forward

Play Episode Listen Later Dec 16, 2020 17:08

SPECIAL EDITION: Moving Forward The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers. Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. Join patients and caregivers across the nation to hear current considerations in the care of PAH. This is the 4th of 4 PAH Today broadcasts to learn about how you can be empowered to stay informed, motivated, and focused on your future. Presented by Dr. Lana Melendres-Groves the Director of the Pulmonary Hypertension Program at the University of New Mexico and PAH patients Denise B. & Lauren J. Learn more at: www.pahinitiative.com Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #ClinicalTrials

director university research blood heart new mexico rare moving forward oxygen asthma lung clinical trials advancements rare diseases pulmonary breathless lung disease pah catheterization united therapeutics pulmonary hypertension program

Episode 355 - PAH Today: The Pathways To Treatment

Play Episode Listen Later Dec 9, 2020 22:50

SPECIAL EDITION: The Pathways To Treatment The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers. Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. Join patients and caregivers across the nation to hear current considerations in the care of PAH. This is the 3rd of 4 PAH Today broadcasts to learn about how medications work to treat PAH and how finding the right combination of medications could help improve your symptoms. Presented by Dr. Lana Melendres-Groves the Director of the Pulmonary Hypertension Program at the University of New Mexico and Dr. Sean M. Studer Chief of Medicine at NYU-Woodhull Medical Center in Brooklyn, New York. Learn more at: www.pahinitiative.com Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #ClinicalTrials

new york director university research blood heart medicine treatments new mexico rare pathways oxygen asthma lung clinical trials advancements rare diseases pulmonary breathless lung disease pah sean m catheterization united therapeutics pulmonary hypertension program

Episode 353 - PAH Today: Shape the Future

Play Episode Listen Later Dec 2, 2020 13:04

SPECIAL EDITION: How Decisions Today Can Shape the Future The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers. Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. Join patients and caregivers across the nation to hear current considerations in the care of PAH. This is the second of 4 PAH Today broadcasts to learn about risk status, an important part of today's approach to treating PAH. You'll hear how risk status gives your healthcare provider a new way to assess your progress, and how it could help determine whether more can be done to improve your symptoms today and down the road. Presented by Dr. Lana Melendres-Groves the Director of the Pulmonary Hypertension Program at the University of New Mexico and Nurse Practitioner Melisa Wilson. Learn more at: www.pahinitiative.com Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #ClinicalTrials

director university research blood heart shape new mexico rare oxygen asthma lung clinical trials advancements rare diseases pulmonary breathless lung disease pah catheterization united therapeutics pulmonary hypertension program

Episode 351 - PAH Today: Beyond the Basics

NGMC Continuing Medical Education

Play Episode Listen Later Nov 25, 2020 20:11

SPECIAL EDITION: Beyond the Basics The PAH Initiative and United Therapeutics are excited to bring you the PAH Today National Broadcast Series. This series of virtual events is intended for adult patients with pulmonary arterial hypertension (PAH) and their caregivers. Advancements in the care and treatment of PAH are improving the lives of those impacted by this life-threatening disease. The National Broadcast Series will include insights and perspectives on today’s approaches to managing PAH from nationally recognized PAH healthcare providers. Join patients and caregivers across the nation to hear current considerations in the care of PAH. This is the first of 4 PAH Today broadcasts to learn more about your symptoms and how your healthcare provider can use them to monitor your PAH. Presented by Dr. Lana Melendres-Groves the Director of the Pulmonary Hypertension Program at the University of New Mexico and Dr. George Ruiz Chief of Cardiology at MedStar Union Memorial Hospital. Learn more at: www.pahinitiative.com Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #ClinicalTrials

director university research blood heart basics new mexico rare oxygen asthma lung clinical trials advancements cardiology rare diseases pulmonary breathless lung disease pah catheterization united therapeutics pulmonary hypertension program

PERT CME:Operationalizing PERT

Play Episode Listen Later Nov 19, 2020 62:10

Enduring CME will expire on 11/19/2022. Presenter: Sara Hegab, MD, Henry Ford Health System, Detroit, MI Objectives - Introduction and Case Presentation - Philosophy and Rationale - Set Up and Initiation - Operations - Performance - Challenges Disclosures - Research support: Henry Ford Hospital receives financial support in the form of research grants from Actelion, Bayer, United Therapeutics and Gilead in the area of pulmonary hypertension - Bayer-Speaker, Advisory Board Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

detroit md credit physicians bayer tm health systems gilead operationalizing pert medical association henry ford health system henry ford hospital ama pra category united therapeutics actelion northeast georgia medical center

PERT CME: Pulmonary Embolism Response Teams: Sometimes It Takes a Village

NGMC Continuing Medical Education

Play Episode Listen Later Nov 16, 2020 66:09

Enduring CME will expire on 11/16/2022. Presenter: Sara Hegab, MD, Henry Ford Health System, Detroit, MI Objectives •Challenges in management of patients with massive and submassivePE •Team based approach to PE management •Post-PE Syndrome Disclosures - Research support: Henry Ford Hospital receives financial support in the form of research grants from Actelion, Bayer, United Therapeutics and Gilead in the area of pulmonary hypertension - Bayer-Speaker, Advisory Board Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

detroit md credit village pe physicians bayer tm health systems gilead pert pulmonary embolism medical association henry ford health system henry ford hospital ama pra category united therapeutics actelion northeast georgia medical center

Working on Lungs outside the body

Fun with the Maryland STEM Festival

Play Episode Listen Later Nov 5, 2020 9:38

Sam Popa, Associate Director, discusses his work at United Therapeutics on lungs outside the body that increases the success rate of donated organs. https://www.unither.com/index.html Follow the Festival on Twitter @mdstemfest, Instagram @mdstem, Facebook @marylandstemfestival and on our website www.marylandstemfestival.org. You can e-mail your thoughts and comments to us at mdstemfest@gmail.com

body festival associate director lungs united therapeutics

S3E8: Making the Impossible Possible: A Conversation with Martine Rothblatt

Steve Forbes: What's Ahead

Play Episode Listen Later Oct 30, 2020 57:05

Martine Rothblatt is the founder and Chairwoman of United Therapeutics as well as the founder of SiriusXM. In her conversation with Steve, she discusses the obstacles she overcame in business, and the fascinating journey to starting her medical company in order to save her daughter.

Innovating for Human Longevity with Dean Kamen and Martine Rothblatt

Future Positive

Play Episode Listen Later Jul 18, 2020 29:24

In this episode, our podcast host Dr. Emily Church looks at how technology is innovating modern medicine at an exponential rate to be smarter and proactive. In a special recording from Visioneering, XPRIZE founder Peter H. Diamandis is joined by two of the world’s greatest entrepreneurs: iBOT & Segway inventor engineer Dean Kamen, and science innovator and founder of United Therapeutics, Martine Rothblatt. They discuss the future of health and medicine where biology IS technology. Drawing from their own inspirational experience, including printing new organs, and eradicating diabetes and Alzheimers, Peter, Dean and Martine discuss the positive impact that innovation is having on human health and longevity. Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world's leaders on exponentially growing technologies. As an entrepreneur, Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education. He is cofounder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company. Diamandis is a New York Times Bestselling author of two books: Abundance – The Future Is Better Than You Think and BOLD – How to go Big, Create Wealth & Impact the World. His newest book in this series of exponential technologies—The Future is Faster Than You Think—was released on January 28, 2020. He earned degrees in molecular genetics and aerospace engineering from the MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is “the best way to predict the future is to create it yourself.”Dr. Martine Rothblatt founded Lung Biotechnology, as well as its parent company, United Therapeutics, in order to develop therapies for orphan diseases such as PAH. She earned her PhD in medical ethics from the Royal London School of Medicine and Dentistry, Queen Mary College, University of London and also obtained JD and MBA degrees from the University of California at Los Angeles. Prior to entering the life sciences field, Dr. Rothblatt was active in satellite communications, founding Sirius XM Satellite Radio and serving as its Chairman and CEO. She has also published many books, including Your Life or Mine: How Geoethics Can Resolve the Conflict Between Public and Private Interests in Xenotransplantation.Dean Kamen, Founder of FIRST and President of DEKA Research & Development CorporationDean Kamen is an inventor, an entrepreneur, and a tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the United States.As an inventor, he holds more than 440 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. While still a college undergraduate, he invented the first wearable infusion pump, which rapidly gained acceptance from such diverse medical specialties as oncology, neonatology, and endocrinology. In 1976, he founded his first medical device company, AutoSyringe, Inc., to manufacture and market the pumps. Then, working with leading diabetes researchers, Dean pioneered the design and adoption of the first portable insulin pump. It was quickly demonstrated that using a pump could much more effectively control patients’ blood glucose levels. . At age 30, he sold AutoSyringe to Baxter Healthcare Corporation. Following the sale of AutoSyringe, Inc., he founded DEKA Research & Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients. Kamen led DEKA's development of the HomeChoiceTM peritoneal dialysis system for Baxter International Inc. The HomeChoiceTM system allows patients to be dialyzed in the privacy and comfort of their home and quickly became the worldwide market leader. Kamen also led the development of technology to improve slide preparation for the CYTYC (now Hologic Inc.) ThinPrep® Pap Test. Kamen-led DEKA teams have also developed critical components of the UVARTM XTSTM System, an extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-Cell lymphoma. An advanced prosthetic arm in development for DARPA should advance the quality of life for returning injured soldiers. Other notable developments include the HydroflexTM surgical irrigation pump for C.R. Bard, the CrownTM stent, an improvement to the original Palmaz-Schatz stent, for Johnson & Johnson, the iBOTTM mobility device, and the Segway® Human Transporter.Kamen has received many awards for his efforts. Notably, Kamen was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award was in recognition for inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Kamen was elected a member of the National Academy of Engineering in 1997. He was awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. He is a Fellow of the American Institute for Medical & Biological Engineering, as well as many other national and international engineering organizations.In 2010, Dean hosted the Planet Green television series Dean of Invention.In addition to DEKA, one of Dean's proudest accomplishments is founding FIRST® (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, this year FIRST® will serve more than 1,000,000 young people, ages 6 to 18, in more than 86 countries around the globe. Last year, high-school-aged participants were eligible to apply for more than $50 million in scholarships from over 200 leading colleges, universities, and corporations.Links: https://www.firstinspires.org/robotics/frchttps://www.unither.com/ See acast.com/privacy for privacy and opt-out information.

united states america ceo university california founders world president science los angeles technology future phd mit medicine hall of fame fortune impact drawing mba fame silicon valley medical engineering alzheimer's disease fellow founded clinton jd your life invention recognition harvard medical school bard notably innovating national academy dentistry university of london new york times bestselling american institute vice chairman martine darpa segway singularity university 250m create wealth kamen xprize national medal pah deka xprize foundation biological engineering t cells development corporation greatest leaders sirius xm satellite radio diamandis dean kamen visioneering human longevity peter h diamandis martine rothblatt united therapeutics queen mary college bold how celularity ibot baxter international inc national inventors hall first for inspiration

Martine Rothblatt

From Scratch with Jessica Harris

Play Episode Listen Later May 29, 2020 31:15

Martine is a pioneer in the satellite industry, launching companies including Geostar, PanAmSat, and Sirius Satellite Radio. She also founded United Therapeutics, a pharmaceutical company focused on cardiopulmonary disorders. In 2013, she became the highest paid female CEO in America. Martine is a helicopter pilot and a parent of four children. She also used to […]

america ceo martine sirius satellite radio martine rothblatt united therapeutics

Printed Body Parts

Good News Good Planet

Play Episode Listen Later May 26, 2020 2:26

For more delicious news, go to www.GoodNewsGoodPlanet.com, and scroll to bottom for more ways to find the feel good stuff!* 3D PRINTED BODY PARTS Organ matches can be hard to come by. Patients typically wait for transplants for months, even years, sometimes dying before receiving them. But now there are companies combating the life-threatening organ shortage with 3D printing. The process is called "Bioprinting" and it uses human tissue cells as “ink”. It actually isn't a new idea. 3D printers can already make human skin and even retinas. But the method has been limited to small, thin tissues that lack blood vessels. New 3D printing technologies could soon change that. The Wake Forest Institute for Regenerative Medicine is creating artificial ears. A hydrogel scaffold is printed and then covered in skin and cartilage cells. These cells propagate, forming an ear-like structure. The original scaffold biodegrades, leaving the newly formed ear behind. By using the patient’s own cells, the organ has less chance of rejection once transplanted. United Therapeutics in New Hampshire is using a similar method to create lungs. A collagen infrastructure is 3D printed and then impregnated with human cells to animate it. The process, called "recellularization" is still in its early stages and not without challenges. The more complex an organ, the more difficult the task. Organs may someday be manufactured in large numbers, not only solving the organ shortage, but also reshaping our life spans. Imagine getting a new heart and lungs when your original ones give out. The future possibilities are exciting, though much further research and testing are still needed. While printing a 3D brain is a long way off, Sharon Presnell—chief scientist of Organovo whose company is 3D printing thin sheets of liver—says, “We all think it’s going to be possible at some point in the future. Where we differ, is on how long it will take.” *Hungry for more of the Good Stuff? Search "Good News Good Planet" on YouTube, Instagram, Patreon, Alexa and wherever you listen to your favorite podcasts.

3d patients hungry new hampshire body parts organs regenerative medicine printed new 3d bioprinting united therapeutics wake forest institute

Episode 319 - Avi Halpert

blood heart vice president north carolina maryland rare asthma rare diseases pulmonary breathless lung disease corporate real estate halpert catheterization united therapeutics

Play Episode Listen Later Mar 30, 2020 11:39

Avi Halpert is Vice President, Corporate Real Estate at United Therapeutics. In this episode, Avi discusses his role of overseeing the development of UT's Silver Spring, Maryland headquarters as well as site development of their North Carolina facilities to meet corporate energy goals. Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware

Martine Rothblatt - Flying Cars & Artificial Organs

ideacity On The Air

Play Episode Listen Later Feb 12, 2020 20:00

Martine and Moses talk about viable ways people can live longer

ceo dna artificial sirius xm martine organs flying cars martine rothblatt united therapeutics

One World One Sphere, Unisphere, AoT#243

Trans Resister Radio

Play Episode Listen Later Sep 3, 2019 59:10

This episode of The Age of Transitions radio show covers the forceful land deals of influential players, transhumanism, and the infamous Octopus conspiracy made famous by Danny Casolaro. The new Unisphere facility, corporate headquarters of United Therapeutics, is a main focus during the conversation. topics include: transhumanism, transhumanists, Martine Rothblatt, biotech, pharmaceuticals, pulmonary arterial hypertension, drugs, Ewing Cole, Maryland flag, Washington DC, Lake Buena Vista, Disney World, Florida, CIA, Danny Casolaro, Indio CA, Cabazon Band of Mission Indians, reservation, Fantasy Springs, Wackenhut, California, tribal land, art, Rachel Haywire, transhumanist party

california washington dc maryland cia disney world transitions octopus sphere one world world one danny casolaro lake buena vista fantasy springs martine rothblatt united therapeutics rachel haywire

United Therapeutics - Glassdoor Review - EP. 8

Clinical Research Podcast

Play Episode Listen Later Jun 22, 2019 35:45

In this episode we talk about United Therapeutics. The first sponsor in the glassdoor review series. I hope you enjoy this one. Don't forget to Subscribe for new content! Subscribe: https://youtube.com/eliteclinicalrese... Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: https://anchor.fm/clinical-research-p... Steemit: https://steemit.com/@ecrgmedia Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: https://goo.gl/fNXpQ5 » All Videos: https://goo.gl/87XEFW » Interview Recaps: https://goo.gl/wJsk6W » Glassdoor Reviews: https://goo.gl/AbQzqe We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/clinical-research-podcast/message Support this podcast: https://anchor.fm/clinical-research-podcast/support

glassdoor steemit united therapeutics

The Wonder Woman who might save your life | Meet Martine Rothblatt, Sirius XM co-founder who now creates life-saving technologies

The Tony Robbins Podcast

Play Episode Listen Later May 24, 2019 56:14

After co-founding SiriusXM Radio, Martine Rothblatt took a leap of faith when her youngest daughter developed a fatal lung illness with no available treatment. Determined to help her daughter, and with no formal background in science or biology, she created United Therapeutics, which developed a lifesaving molecule that not only saved her daughter, but tens of thousands of others in the process – proving that when your WHY is strong enough, you’ll find the HOW. In this exclusive interview with Tony Robbins at one of his business seminars, Martine shares how she has built her entire career on achieving the seemingly impossible, and also reveals her own process for turning visionary ideas into technology that changes lives.

technology co founders radio wonder woman transgender creates tony robbins determined sirius xm robbins sirius martine lifesaving save your life therapeutics sirius xm radio xm martine rothblatt united therapeutics

FirstWord Pharmaceutical News for Thursday, November 15 2018

money focus investing healthcare fool stocks brink motley united therapeutics amarin

Play Episode Listen Later Nov 15, 2018 5:09

Today in FirstWord:

pharmaceutical novartis first word boehringer ingelheim united therapeutics arena pharmaceuticals uniqure

Healthcare: MannKind's Back from the Brink

Industry Focus

Play Episode Listen Later Sep 5, 2018 27:32

A new cash lifeline from United Therapeutics buys the diabetes drugmaker more time to increase sales of its inhaled insulin. Also, make-or-break news is fast approaching for cardiovascular drugmaker, Amarin. MNKD, UTHR, AMRN

021 — Dr. Martine Rothblatt: A Genius Mind and a Noble Heart

MizMaryland | Soul Force Politics

Play Episode Listen Later Apr 18, 2018 52:17

Today’s guest is a truly remarkable genius, tenacious innovator, and creative problem solver. She also happens to be one of the kindest, most generous, and caring humans I have met. If you have never heard Martine Rothblatt speak of the many ways she has conquered the impossible, then buckle up for a sweet ride on today’s show where we meet the blending of a genius mind with a noble heart. Her insatiable curiosity has produced everything from satellite radio and life-saving pharmaceuticals to improved lung transplantation techniques, development of potential pig-to-human organ transplants, to the first prototypes for electric helicopters, and building robotic cybernetic companions. She is a futurist of the highest order – one that does not just predict; Martine Rothblatt DELIVERS. She has a law degree, an MBA, and a PhD in medical ethics. Dr. Rothblatt is the founder and former CEO and Chairman of Sirius XM satellite radio, the founding CEO and pioneer of an orphan drug at United Therapeutics that saved the life of her own child before making millions of dollars saving the lives of others, and a futurist that tells us what she sees in the fields of artificial intelligence, mind files, and the exploration of consciousness. Each week at the end of our show, you hear me encourage you with words that I use as my own personal daily mantra: Be the change you want to see. Create the world you want to manifest. Break through the illusions of impossibility. Live your life’s purpose with clarity, intention, and truth. Choose only love. Be. ONE. Martine Rothblatt encompasses all of this in the most magnificent way. Thank you for joining us today to listen to her wisdom. ______________ In the first video below, Morgan Freeman meets the robot Bina 48 on his National Geographic show, “The Story of God.” And after seeing this, Whoopi Goldberg went to interview Martine and Bina Rothblatt for a segment for ABC’s “The View.” Martine Rothblatt was named one of the “100 Greatest Living Business Minds” by Forbes Magazine

FirstWord Pharmaceutical News for Monday, August 7 2017

pharmaceutical glaxosmithkline first word gilead sciences united therapeutics

Play Episode Listen Later Aug 7, 2017 1:48

Today in FirstWord:

#067: Shola: A CIO's Journey To Solving Global Grand Health Challenges| Lessons in Innovation| Mentorship| & Continuous Learning

Bill Murphy's RedZone Podcast | World Class IT Security

Play Episode Listen Later Jan 6, 2017 37:57

My guest for this episode is Shola Oyewole, CIO of United Therapeutics. As a member of the Senior Executive Leadership of United Therapeutics Corporation, Shola provides technology, vision, and leadership in the development and implementation of the global information technology (IT) program. In that role he supports the Finance, HR, R&D, Manufacturing, Sales & Marketing, and various business units in planning and implementing enterprise information systems to support both distributed and centralized business operations, and achieve more effective and cost beneficial enterprise-wide IT operations. Additionally, Shola provides strategic and tactical planning, budget development, evaluation, and coordination of the information and technology systems for the corporation. He facilitates communication between staff, management, vendors, and other technology resources within (and outside) of the organization. Major Take-Aways From This Episode: 1. In our discussion we highlighted the importance of continuous learning in not just tech domain but all elements leadership, innovation and team building for example. 2. The Importance of mentors. 3. Innovation and help desk ideas that will spark your imagination 4. Branding and marketing an IT Dpt. Click here see an example of the logo below for his team that was developed related to the marketing and branding of the IT department. 5. Stories of how Shola said 'Yes' to requests his CEO made that lead to major new sources of revenue for the company. Ways to connect with SholaPrabhash Shrestha: LinkedIn Twitter Other Resources: United Therapeutics Website Advanced Therapies For Patients Suffering with PAH, CIO Review Harvard Business School Classes Singularity University Click Here for Time Stamped Show Notes Sponsored By: ________________________________________ This episode is sponsored by the CIO Security Scoreboard, a powerful tool that helps you communicate the status of your IT Security program visually in just a few minutes. ________________________________________ Credits: Outro music provided by Ben's Sound Other Ways To Listen to the Podcast iTunes | Libsyn | Soundcloud | RSS Feed | LinkedIn Leave a Review If you enjoyed this episode, then please consider leaving an iTunes review here. Click here for instructions on how to leave a review if you're doing this for the first time. About Bill Murphy Bill Murphy is a world renowned IT Security Expert dedicated to your success as an IT business leader. Follow Bill on LinkedIn and Twitter.

ceo stories lessons innovation global finance branding mentorship manufacturing cio r d sales marketing continuous learning health challenges it security pah shola united therapeutics

FirstWord Pharmaceutical News for Wednesday, March 11, 2015

bayer pharmaceutical glaxosmithkline first word united therapeutics

Play Episode Listen Later Mar 11, 2015 1:39

Today in FirstWord:

FirstWord Pharmaceutical News for Monday, September 1, 2014

pharmaceutical novartis eli lilly sanofi takeda regeneron first word united therapeutics

Play Episode Listen Later Sep 1, 2014 19:52

Today in FirstWord:

FirstWord Pharmaceutical News for Tuesday, March 26, 2013